We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+5.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$185M
AUM Growth
-$21.9M
(-11%)
Cap. Flow
+$579K
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
38.04%
Holding
415
New
80
Increased
38
Reduced
43
Closed
102
Avg Time Held Equity + Options
1.8
quarters
Top 10 Avg Time Held Equity + Options
0.8
quarters
Top 20 Avg Time Held Equity + Options
1.2
quarters
Avg Time Held Equity only
1.9
quarters
Top 10 Avg Time Held Equity only
1.3
quarters
Top 20 Avg Time Held Equity only
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$4.64M |
| 2 |
Lindsay Corp
LNN
|
+$2.12M |
| 3 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$1.77M |
| 4 |
Boston Scientific
BSX
|
+$1.51M |
| 5 |
Verizon
VZ
|
+$1.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$4.34M |
| 2 |
3D Systems Corp
DDD
|
+$1.86M |
| 3 |
Lennar Class A
LEN
|
+$989K |
| 4 |
BlackBerry
BB
|
+$938K |
| 5 |
Vince Holding Corp
VNCE
|
+$928K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.91% |
| 2 | Miscellaneous | 27.85% |
| 3 | Healthcare | 13.47% |
| 4 | Technology | 9.49% |
| 5 | Consumer Discretionary | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Filana Therapeutics
FLNA
$37.2M
| $138K | 0.07% |
+3,571
| New | +$126K |
2014 Q1
0 quarters
|
|
|
FCSC
177
DELISTED
Fibrocell Science Inc.
FCSC
| $131K | 0.07% |
1,667
-666
| -29% | -$51.6K |
2013 Q4
1 quarter
|
|
178
DELISTED
Emcore Corp
EMKR
| $126K | 0.07% |
2,500
| – | – |
2013 Q4
1 quarter
|
|
|
XWES
179
DELISTED
WORLD ENERGY SOLUTIONS INC NEW COMMON (DE)
XWES
| $121K | 0.07% |
25,000
| – | – |
2013 Q2
3 quarters
|
|
|
JMBA
180
DELISTED
Jamba, Inc.
JMBA
| $120K | 0.06% |
10,000
| – | – |
2013 Q4
1 quarter
|
|
181
Ur-Energy
URG
$367M
| $116K | 0.06% |
+75,000
| New | +$113K |
2014 Q1
0 quarters
|
|
182
Alaunos Therapeutics
TCRT
$2.67M
| $115K | 0.06% |
167
| – | – |
2013 Q3
2 quarters
|
|
183
iShares MSCI Japan ETF
EWJ
$23.7B
| $113K | 0.06% |
2,500
| – | – |
2013 Q4
1 quarter
|
|
184
CALL
Xerox
XRX
$356M
| $113K | 0.06% |
3,795
| – | – |
2013 Q3
2 quarters
|
|
|
ANR
185
DELISTED
Alpha Natural Resources Inc
ANR
| $106K | 0.06% |
25,000
| – | – |
2013 Q4
1 quarter
|
|
186
DELISTED
Cantaloupe
CTLP
| $104K | 0.06% |
50,000
-118,996
| -70% | -$249K |
2013 Q4
1 quarter
|
|
187
DELISTED
AMERICAN APPAREL INC COM
APP
| $100K | 0.05% |
200,000
+44,500
| +29% | +$40.4K |
2013 Q2
3 quarters
|
|
188
Digital Turbine
APPS
$1.29B
| $99K | 0.05% |
+25,000
| New | +$96K |
2014 Q1
0 quarters
|
|
189
Fortress Biotech
FBIO
$70.4M
| $99K | 0.05% |
3,333
| – | – |
2013 Q2
3 quarters
|
|
|
NM
190
DELISTED
Navios Maritime Holdings Inc.
NM
| $99K | 0.05% |
1,000
| – | – |
2013 Q2
3 quarters
|
|
191
Safe Bulkers
SB
$984M
| $95K | 0.05% |
10,000
| – | – |
2013 Q2
3 quarters
|
|
|
RTK
192
DELISTED
Rentech, Inc.
RTK
| $95K | 0.05% |
5,000
| – | – |
2013 Q2
3 quarters
|
|
193
NovaGold Resources
NG
$2.95B
| $90K | 0.05% |
+25,000
| New | +$85.2K |
2014 Q1
0 quarters
|
|
194
Denison Mines
DNN
$2.15B
| $74K | 0.04% |
+50,000
| New | +$70.4K |
2014 Q1
0 quarters
|
|
195
Oragenics
OGEN
$2.02M
| $72K | 0.04% |
1
| – | – |
2013 Q4
1 quarter
|
|
196
Option Care Health
OPCH
$4.66B
| $70K | 0.04% |
+2,505
| New | +$77.3K |
2014 Q1
0 quarters
|
|
197
Cerenome
CNSY
$13.7M
| – | – |
0
| – | – |
2013 Q2
3 quarters
|
|
198
DELISTED
Christopher & Banks Corporation
CBK
| $66K | 0.04% |
10,000
-5,000
| -33% | -$34.1K |
2013 Q4
1 quarter
|
|
|
DMK
199
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $64K | 0.03% |
143
-214
| -60% | -$97.1K |
2013 Q4
1 quarter
|
|
200
Aware
AWRE
$21.8M
| $58K | 0.03% |
10,000
| – | – |
2013 Q4
1 quarter
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q1 2014 Portfolio in Review
As of Q1 2014, E.E. Geduld held 415 positions worth $185M, down 11% from $207M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
E.E. Geduld's Q1 2014 filing shows 80 new, 38 increased, 43 reduced and 102 closed positions. Its largest new stake was Johnson & Johnson: 50,000 shares worth $4.91M. The largest sale was Ariad Pharmaceuticals Inc, an estimated $4.34M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Healthcare.
- E.E. Geduld's largest Q1 2014 buy was Johnson & Johnson: 50,000 shares worth $4.91M.
- E.E. Geduld added most to Boston Scientific in Q1 2014, an estimated $1.51M increase.
- E.E. Geduld's biggest Q1 2014 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $4.34M.
- E.E. Geduld fully exited 3D Systems Corp in Q1 2014, selling an estimated $1.86M.
- E.E. Geduld's ten largest holdings make up 38% of its $185M portfolio in Q1 2014.
- E.E. Geduld opened 80 new positions and closed 102 in Q1 2014.
- E.E. Geduld's portfolio value fell 11% quarter-over-quarter to $185M.
Based on E.E. Geduld's 13F filing for Q1 2014, filed 7 May 2014.